Recent Quotes View Full List My Watchlist Create Watchlist Indicators DJI Nasdaq Composite SPX Gold Crude Oil EL&P Market Index Markets Stocks ETFs Tools Overview News Currencies International Treasuries Articles published by Savara Inc. < Previous 1 2 Next > Savara Announces New Employment Inducement Grant August 16, 2024 From Savara Inc. Via Business Wire Tickers SVRA Savara to Present New Data from Pivotal Phase 3 IMPALA-2 Trial of Molgramostim Nebulizer Solution (Molgramostim) in Patients with Autoimmune Pulmonary Alveolar Proteinosis (aPAP) at the European Respiratory Society (ERS) Congress 2024 August 15, 2024 From Savara Inc. Via Business Wire Tickers SVRA Savara Reports Second Quarter 2024 Financial Results and Provides Business Update August 12, 2024 From Savara Inc. Via Business Wire Tickers SVRA Savara Announces Pricing of $100.0 Million Underwritten Offering of Common Stock June 28, 2024 From Savara Inc. Via Business Wire Tickers SVRA Savara Announces Molgramostim Nebulizer Solution (Molgramostim) Achieved Statistical Significance for Primary Endpoint and Multiple Secondary Endpoints in IMPALA-2, a Pivotal Phase 3 Clinical Trial in Autoimmune Pulmonary Alveolar Proteinosis (aPAP) June 26, 2024 From Savara Inc. Via Business Wire Tickers SVRA Savara to Host Investor Call to Discuss Top Line Results From Pivotal Phase 3 IMPALA-2 Trial of Molgramostim Nebulizer Solution (Molgramostim) in Patients With Autoimmune Pulmonary Alveolar Proteinosis (aPAP) June 25, 2024 From Savara Inc. Via Business Wire Tickers SVRA Savara to Present at the Jefferies Global Healthcare Conference May 29, 2024 From Savara Inc. Via Business Wire Tickers SVRA Savara Presented New Data on Autoimmune Pulmonary Alveolar Proteinosis (aPAP) at the American Thoracic Society (ATS) International Conference 2024 May 19, 2024 From Savara Inc. Via Business Wire Tickers SVRA Savara Announces New Employment Inducement Grant May 16, 2024 From Savara Inc. Via Business Wire Tickers SVRA Savara Reports First Quarter 2024 Financial Results and Provides Business Update May 09, 2024 From Savara Inc. Via Business Wire Tickers SVRA Savara to Present at the Citizens JMP Life Sciences Conference May 07, 2024 From Savara Inc. Via Business Wire Tickers SVRA Savara to Present New Data on Autoimmune Pulmonary Alveolar Proteinosis (aPAP) at the American Thoracic Society (ATS) International Conference 2024 April 08, 2024 From Savara Inc. Via Business Wire Tickers SVRA Savara Announces New Employment Inducement Grant March 22, 2024 From Savara Inc. Via Business Wire Tickers SVRA Savara Reports Fourth Quarter/Year-End 2023 Financial Results and Provides Business Update March 07, 2024 From Savara Inc. Via Business Wire Tickers SVRA Savara to Present at the Barclays 26th Annual Global Healthcare Conference March 06, 2024 From Savara Inc. Via Business Wire Tickers SVRA Savara Announces New Employment Inducement Grant February 02, 2024 From Savara Inc. Via Business Wire Tickers SVRA Savara to Present at Two Upcoming Healthcare Conferences January 31, 2024 From Savara Inc. Via Business Wire Tickers SVRA Savara Introduces aPAP ClearPath™, a GM-CSF Autoantibody Blood Test to Detect Autoimmune Pulmonary Alveolar Proteinosis (aPAP) December 21, 2023 From Savara Inc. Via Business Wire Tickers SVRA Savara Added to the NASDAQ Biotechnology Index December 20, 2023 From Savara Inc. Via Business Wire Tickers SVRA Savara Announces New Employment Inducement Grant December 15, 2023 From Savara Inc. Via Business Wire Tickers SVRA Savara to Present at the Piper Sandler 35th Annual Healthcare Conference November 21, 2023 From Savara Inc. Via Business Wire Tickers SVRA Savara Reports Third Quarter Financial Results and Provides Business Update November 09, 2023 From Savara Inc. Via Business Wire Tickers SVRA Savara to Present at the Jefferies London Healthcare Conference November 08, 2023 From Savara Inc. Via Business Wire Tickers SVRA Savara Announces New Employment Inducement Grant October 06, 2023 From Savara Inc. Via Business Wire Tickers SVRA Savara to Present at the H.C. Wainwright 25th Annual Global Investment Conference September 05, 2023 From Savara Inc. Via Business Wire Tickers SVRA Savara Reports Second Quarter Financial Results and Provides Business Update August 10, 2023 From Savara Inc. Via Business Wire Tickers SVRA Savara Announces New Employment Inducement Grant August 04, 2023 From Savara Inc. Via Business Wire Tickers SVRA Savara Announces Pricing of $80 Million Underwritten Offering of Common Stock and Pre-Funded Warrants July 13, 2023 From Savara Inc. Via Business Wire Tickers SVRA Savara Added to Russell 3000® Index June 26, 2023 From Savara Inc. Via Business Wire Tickers SVRA Savara Completes Enrollment of Pivotal Phase 3 IMPALA-2 Trial of Molgramostim Nebulizer Solution (Molgramostim) in Autoimmune Pulmonary Alveolar Proteinosis (aPAP) June 26, 2023 From Savara Inc. Via Business Wire Tickers SVRA < Previous 1 2 Next > Data & News supplied by www.cloudquote.io Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions.